Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00509626 · ClinicalTrials.gov registry record · Phase 1
Physical Activity or Usual Care in Preventing Weight Gain in Women With Stage I or Stage II Breast Cancer Undergoing Chemotherapy
A Phase 1 study, sponsored by Fox Chase Cancer Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 380
- Enrollment target
NCT00509626 is a Phase 1 study that has completed, run by Fox Chase Cancer Center. The registered enrollment target is 380 participants.
The verdict
NCT00509626, a Phase 1 study, has completed, sponsored by Fox Chase Cancer Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 380 participants
- Enrollment target
Study Summary
RATIONALE: Physical activity may prevent or reduce weight gain in women receiving chemotherapy for early stage breast cancer. PURPOSE: This randomized phase I/II trial is studying physical activity to see how well it works compared with usual care to prevent or reduce weight gain in women with stage I or stage II breast cancer undergoing chemotherapy.
Interventions
- OTHER questionnaire administration
- BEHAVIORAL exercise intervention
- PROCEDURE psychosocial assessment and care
- PROCEDURE management of therapy complications
- PROCEDURE CAM exercise therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 380 participants |
| Start Date | 2007-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00509626
The ClinicalTrials.gov registry entry for NCT00509626 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 380 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fox Chase Cancer Center, which has 183 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which questionnaire administration is the first listed.
NCT00509626 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00509626 about?
NCT00509626 is a clinical study titled "Physical Activity or Usual Care in Preventing Weight Gain in Women With Stage I or Stage II Breast Cancer Undergoing Chemotherapy". RATIONALE: Physical activity may prevent or reduce weight gain in women receiving chemotherapy for early stage breast cancer. PURPOSE: This randomized phase I/II trial is studying physical activity to see how well it works compared with usual care to prevent or reduce weight gain in women with stag...
What is the current status of trial NCT00509626?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 380 participants. The study started on 2007-06.
What interventions are being tested in trial NCT00509626?
The interventions under investigation include: questionnaire administration (OTHER), exercise intervention (BEHAVIORAL), psychosocial assessment and care (PROCEDURE), management of therapy complications (PROCEDURE), CAM exercise therapy (PROCEDURE).
Who is sponsoring clinical trial NCT00509626?
This trial is sponsored by Fox Chase Cancer Center, which has 183 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.